CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teva Pharmaceuticals International GmbH v. Eli Lilly and Company

1:18-cv-10242

Overview

Case Number 1:18-cv-10242
Filing Date 2018-02-06
Status Terminated
Termination Date 2018-09-27
Court District Court, D. Massachusetts (mad)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:2201 Declaratory Judgment
Jury Demand Plaintiff

Parties

Defendant

Eli Lilly and Company Operating Company

Represented By

5 Attorneys Listed

Andrea L. Martin

Burns & Levinson LLP

Tel: +1 (617) 345-3000
Fax: +1 (617) 345-3299

125 Summer Street, Boston, MA 02110

William B Raich

Finnegan Henderson Farabow Garrett & Dunner, LLP

Tel: +1 (202) 408-4054

901 New York Avenue, NW, Washington, DC 20001-4413

Emily R. Gabranski

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Tel: +1 (202) 408-4331

Two Seaport Lane, 6th Flr., Boston, MA 02210-2001

Danielle A. Duszczyszyn

Finnegan Henderson Farabow Garrett & Dunner, LLP

Tel: +1 (202) 408-4142

901 New York Avenue, NW, Washington, DC 20001-4413

Charles E. Lipsey

Finnegan,Henderson,Farabow,Garrett & Dunner, LLP.

Tel: +1 (571) 203-2700
Fax: +1 (202) 408-4400

Two Freedom Square, 11955 Freedom Drive

Plaintiff

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

2 Attorneys Listed

Elaine Herrmann Blais

Goodwin Procter, LLP

Tel: +1 (617) 570-1205
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Douglas J. Kline

Goodwin Procter, LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Teva Pharmaceuticals International GmbH Operating Company

Represented By

2 Attorneys Listed

Elaine Herrmann Blais

Goodwin Procter, LLP

Tel: +1 (617) 570-1205
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Douglas J. Kline

Goodwin Procter, LLP

Tel: +1 (617) 570-1000
Fax: +1 (617) 523-1231

100 Northern Avenue, Boston, MA 02210

Court & Judges

Court

District Court, D. Massachusetts (mad)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

12

Dispositive

8

Granted

1

Denied

0

Pending / Review

10

Motions by Category

Procedural / Extension Motion 4 Motion to Dismiss (FRCP 12(b)(6)) 5 Motion to Dismiss 3

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
Judge Allison D. Burroughs: ELECTRONIC ORDER entered. Plaintiff's motion for leave to file a supplemental brief [ECF No. 18 ] is GRANTED, and Defendant may also...
Entry #20 • 2018-06-07 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
BRIEF by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc. to 13 MOTION to Dismiss for Lack of Jurisdiction Motion to Dismiss First Amende...
Entry #21 • 2018-06-07 Document →
Motion to Dismiss Pending / Under Review
Opposition re 18 MOTION for Leave to File a Supplemental Brief in Opposition to Defendant's Motion to Dismiss filed by Eli Lilly and Company. (Attachments: # 1 ...
Entry #19 • 2018-05-29 Document →
Motion to Dismiss Pending / Under Review
MOTION for Leave to File a Supplemental Brief in Opposition to Defendant's Motion to Dismiss by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals US...
Entry #18 • 2018-05-15 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
MEMORANDUM in Opposition re 13 MOTION to Dismiss for Lack of Jurisdiction Motion to Dismiss First Amended Complaint under FRCP 12(b)(1) and partially 12(b)(6) f...
Entry #17 • 2018-03-14 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
MOTION to Dismiss for Lack of Jurisdiction Motion to Dismiss First Amended Complaint under FRCP 12(b)(1) and partially 12(b)(6) by Eli Lilly and Company.(Martin...
Entry #13 • 2018-02-28 Document →

Docket Entries

(92 total)
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 400, receipt number 0101-6997916 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Civil Category Sheet, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31)(Kline, Douglas) (Entered: 02/06/2018)

Entry #1 • 2018-02-06
1
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 400, receipt number 0101-6997916 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Civil Category Sheet, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31)(Kline, Douglas) (Entered: 02/06/2018)

Entry #1 • 2018-02-06
2
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 400, receipt number 0101-6997916 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Civil Category Sheet, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31)(Kline, Douglas) (Entered: 02/06/2018)

Entry #1 • 2018-02-06
2
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 400, receipt number 0101-6997916 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Civil Category Sheet, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31)(Kline, Douglas) (Entered: 02/06/2018)

Entry #1 • 2018-02-06
2
Pleading / Complaint

COMPLAINT against Eli Lilly and Company Filing fee: $ 400, receipt number 0101-6997916 (Fee Status: Filing Fee paid), filed by Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Civil Category Sheet, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31)(Kline, Douglas) (Entered: 02/06/2018)

Entry #1 • 2018-02-06
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc